How to buy IQVIA (IQV) stocks

IQVIA is a diagnostics & research business based in the US. IQVIA shares (IQV) are listed on the NYSE and all prices are listed in US Dollars.

Its last market close was $197.27 – a decrease of 0.9% over the previous week. IQVIA employs 88,000 staff and has a trailing 12-month revenue of around $15.3 billion.

Our top picks for where to buy IQVIA stock

Buy IQVIA stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

IQVIA stock price (NYSE: IQV)

Use our graph to track the performance of IQV stocks over time.

IQVIA stocks at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$197.27
52-week range	$187.62 - $261.73
50-day moving average more info button	$211.57
200-day moving average more info button	$228.56
Wall St. target price	$249.52
PE ratio more info button	25.0946
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$7.61

Is it a good time to buy IQVIA stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

IQVIA price performance over time

Historical closes compared with the close of $191.52 from 2024-12-19

1 week (2024-12-13)	-3.79%
1 month (2024-11-21)	-3.08%
3 months (2024-09-20)	-20.90%
6 months (2024-06-21)	-11.44%

1 year (2023-12-21)	-16.49%
2 years (2022-12-21)	-6.37%
3 years (2021-12-21)	268.63
5 years (2019-12-20)	22.81%

Is IQVIA stock undervalued or overvalued?

Valuing IQVIA stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of IQVIA's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

IQVIA's P/E ratio

IQVIA's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 25x. In other words, IQVIA shares trade at around 25x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the stock or simply that they're under-valued.

IQVIA's PEG ratio

IQVIA's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0384. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into IQVIA's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

IQVIA's EBITDA

IQVIA's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.8 billion.

The EBITDA is a measure of a IQVIA's overall financial performance and is widely used to measure a its profitability.

IQVIA financials

Revenue TTM	$15.3 billion
Operating margin TTM	14.84%
Gross profit TTM	$5 billion
Return on assets TTM	5.11%
Return on equity TTM	22%
Profit margin	9.17%
Book value	$38.37
Market Capitalization more info button	$34.7 billion

TTM: trailing 12 months

IQVIA stock dividends

We're not expecting IQVIA to pay a dividend over the next 12 months.

IQVIA stock price volatility

Over the last 12 months, IQVIA's stocks have ranged in value from as little as $187.62 up to $261.73. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NYSE average) beta is 1, while IQVIA's is 1.513. This would suggest that IQVIA's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

IQVIA overview

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services.

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of IQVIA is owned by insiders or institutions?
Currently 0.924% of IQVIA stocks are held by insiders and 94.504% by institutions. How many people work for IQVIA?
Latest data suggests 88,000 work at IQVIA. When does the fiscal year end for IQVIA?
IQVIA's fiscal year ends in December. Where is IQVIA based?
IQVIA's address is: 2400 Ellis Road, Durham, NC, United States, 27703 What is IQVIA's ISIN number?
IQVIA's international securities identification number is: US46266C1053 What is IQVIA's CUSIP number?
IQVIA's Committee on Uniform Securities Identification Procedures number is: 74876Y101

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.